Press "Enter" to skip to content

Medical Authorities Continue to Block Effective Covid Treatment

The conflict of interest between clinical trials of drugs that determine their effectiveness and safety and the pharmaceutical industry that funds most of the trials is astonishing.  Yet nothing is done about it.  Two-thirds of the Federal Food and Drug Administration’s budget for evaluating prescription drugs comes from the industry that the FDA regulates.  In other words, the regulator is financed by the entity that it is supposed to regulate.

“Human Drugs regulatory activities account for 33 percent of FDA’s budget; 65 percent of these activities are paid for by industry user fees (Oct 18, 2019).” — 

It is this corrupt conflict of interest that has blocked the HCQ treatment of Covid-19. Hundreds of thousands of people have died and many others have been left with impaired health, because Big Pharma used its influence over the FDA, NIH, CDC, and WHO to keep the pandemic alive until a vaccine could be rushed to market.  In other words, profit, not health, has been the goal.

Medical journals themselves have been corrupted.  Dr. Marcia Angell, former editor of the new England Journal of Medicine says that “it is simply no longer possible to believe much of the clinical research that is pubished.”  What passes for research is concocted “studies” to clear a drug for marketing.  

This article discusses these themes: 

This article provides details of the conspiracy between US public health agencies, the medical profession, and Big Pharma to sideline HCQ and clear Remdesiir at a cost of $3,120 per patients— 

HCQ costs a couple of dollars.

Your use of this website indicates your agreement to these Terms of Service.

All content posted on this site is commentary or opinion and is protected under the 1st Amendment of the United States of America. Hope Holdings and Providence Post are not responsible for content written by contributing authors. The information on this site is provided for educational and entertainment purposes only. Hope Holdings and Providence Post assume no responsibility for the use or misuse of this material. All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners. You must ask permission from them directly to reuse or repost.

This site is a Hope Holdings company website © 2019 All Rights Reserved.